104 related articles for article (PubMed ID: 23416028)
1. [Main results of the colorectal cancer screening program in the Basque Country (Spain)].
Portillo I; Idígoras I; Ojembarrena E; Arana-Arri E; Zubero MB; Pijoán JI; López Urrutia A; Marqués ML
Gac Sanit; 2013; 27(4):358-61. PubMed ID: 23416028
[TBL] [Abstract][Full Text] [Related]
2. [Lesions detected in a colorectal cancer screening program in the Basque Country: first round (2009-2011)].
Portillo I; Idígoras I; Ojembarrena E; Arana E; Luis Hurtado J; Basurko R; Tapia M; Luz Peña M
Gastroenterol Hepatol; 2013 May; 36(5):301-8. PubMed ID: 23618538
[TBL] [Abstract][Full Text] [Related]
3. [Colorectal cancer screening programme in Aragon (Spain): preliminary results].
Solé Llop ME; Cano Del Pozo M; García Montero JI; Carrera-Lasfuentes P; Lanas Á
Gac Sanit; 2018; 32(6):559-562. PubMed ID: 28784304
[TBL] [Abstract][Full Text] [Related]
4. [The usefulness of fecal tests in colorectal cancer screening].
Castells A
Gastroenterol Hepatol; 2014 Sep; 37 Suppl 3():71-6. PubMed ID: 25294268
[TBL] [Abstract][Full Text] [Related]
5. [Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmacies].
Burón A; Grau J; Andreu M; Augé JM; Guayta-Escolies R; Barau M; Macià F; Castells A;
Med Clin (Barc); 2015 Aug; 145(4):141-6. PubMed ID: 25073826
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing participation in colorectal cancer screening programs in Spain.
Vanaclocha-Espi M; Ibáñez J; Molina-Barceló A; Pérez E; Nolasco A; Font R; Pérez-Riquelme F; de la Vega M; Arana-Arri E; Oceja M; Espinàs JA; Portillo I; Salas D;
Prev Med; 2017 Dec; 105():190-196. PubMed ID: 28887191
[TBL] [Abstract][Full Text] [Related]
7. [Actitudes e imágenes sociales sobre el cribado de cáncer colorrectal. Una aproximación exploratoria mediante grupos de discusión.].
de Haro Gázquez D; Fernández Sánchez B; Amador Muñoz ML
Rev Esp Salud Publica; 2023 Aug; 97():. PubMed ID: 37970927
[TBL] [Abstract][Full Text] [Related]
8. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
Parente F; Boemo C; Ardizzoia A; Costa M; Carzaniga P; Ilardo A; Moretti R; Cremaschini M; Parente EM; Pirola ME
Endoscopy; 2013; 45(1):27-34. PubMed ID: 23254404
[TBL] [Abstract][Full Text] [Related]
9. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
Webendörfer S; Riemann JF
Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
[TBL] [Abstract][Full Text] [Related]
10. Factors related to the participation and detection of lesions in colorectal cancer screening programme-based faecal immunochemical test.
Portillo I; Arana-Arri E; Gutiérrez-Ibarluzea I; Bilbao I; Luis Hurtado J; Sarasqueta C; Idigoras I; Bujanda L;
Eur J Public Health; 2018 Dec; 28(6):1143-1148. PubMed ID: 29982586
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model.
Idigoras I; Arrospide A; Portillo I; Arana-Arri E; Martínez-Indart L; Mar J; de Koning HJ; Lastra R; Soto-Gordoa M; van der Meulen M; Lansdorp-Vogelaar I
BMC Public Health; 2017 Aug; 18(1):78. PubMed ID: 28764731
[TBL] [Abstract][Full Text] [Related]
12. [Lesions Detected in Six Spanish Colorectal Cancer Screening Population Based Programmes. CRIBEA Project. Spain].
Portillo Villares I; Arana-Arri E; Idigoras Rubio I; Espinás Piñol JA; Pérez Riquelme F; de la Vega Prieto M; González Aledo A; Oceja Setien E; Vanaclocha Espi M; Ibáñez Cabanell J; Salas Trejo D;
Rev Esp Salud Publica; 2017 Feb; 91():. PubMed ID: 28218734
[TBL] [Abstract][Full Text] [Related]
13. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
Rabeneck L; Tinmouth JM; Paszat LF; Baxter NN; Marrett LD; Ruco A; Lewis N; Gao J
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):508-15. PubMed ID: 24443406
[TBL] [Abstract][Full Text] [Related]
14. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.
Garcia M; Borràs JM; Binefa G; Milà N; Espinàs JA; Moreno V
Eur J Cancer Prev; 2012 Jan; 21(1):42-5. PubMed ID: 21849903
[TBL] [Abstract][Full Text] [Related]
15. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
16. Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe.
Toes-Zoutendijk E; Portillo I; Hoeck S; de Brabander I; Perrin P; Dubois C; van Leerdam M; Lansdorp-Vogelaar I; Bardou M
J Med Screen; 2020 Jun; 27(2):68-76. PubMed ID: 31645173
[TBL] [Abstract][Full Text] [Related]
17. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
18. A feces collection paper does not enhance participation in a fecal immunochemical test-based colorectal cancer screening program: randomized clinical trial.
Denters MJ; Deutekom M; Bossuyt PM; Fockens P; Dekker E
Eur J Cancer Prev; 2013 Jul; 22(4):299-304. PubMed ID: 23169243
[TBL] [Abstract][Full Text] [Related]
19. Participation and detection rates by age and sex for colonoscopy versus fecal immunochemical testing in colorectal cancer screening.
Salas D; Vanaclocha M; Ibáñez J; Molina-Barceló A; Hernández V; Cubiella J; Zubizarreta R; Andreu M; Hernández C; Pérez-Riquelme F; Cruzado J; Carballo F; Bujanda L; Sarasqueta C; Portillo I; de la Vega-Prieto M; Morillas JD; Valentín V; Lanas A; Quintero E; Castells A
Cancer Causes Control; 2014 Aug; 25(8):985-97. PubMed ID: 24859111
[TBL] [Abstract][Full Text] [Related]
20. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]